文献速递生殖医学

左炔诺孕酮释放宫内系统预处理对子宫腺肌病女性体外受精及玻璃化冷冻复苏胚胎移植结局的影响

Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis.
PubMed 文献 · Reprod Biomed Online · 2019-03-11

这项回顾性研究纳入358例子宫腺肌病行体外受精的女性,其中左炔诺孕酮释放宫内系统(LNG-IUS)组134例、对照组224例,所有比较均为玻璃化冷冻复苏胚胎移植。LNG-IUS组与对照组的持续妊娠率分别为41.8%和29.5%(P=0.017),校正OR=1.628(95%CI 1.011-2.622);着床率分别为32.1%和22.1%(P=0.005),临床妊娠率分别为44%和33.5%(P=0.045)。作者认为该结果对未来随机对照试验评估LNG-IUS预处理效果提供了一定支持。

要点

  • LNG-IUS组持续妊娠率41.8%,对照组29.5%(P=0.017)。
  • LNG-IUS组着床率32.1%,对照组22.1%(P=0.005)。
  • LNG-IUS组临床妊娠率44%,对照组33.5%(P=0.045)。

核心结论

  • 本研究结果对未来随机对照试验评估LNG-IUS预处理在子宫腺肌病女性中的效果提供了一定支持。

研究设计与样本

  • 回顾性研究纳入358例子宫腺肌病行体外受精的女性,LNG-IUS组134例,对照组224例。
  • 所有女性均经阴道超声和磁共振成像(MRI)筛查子宫腺肌病。
  • 两组女性年龄、FSH、不孕原因、体重指数、促性腺激素总剂量及获卵数无显著差异。
  • 所有比较均为玻璃化冷冻复苏胚胎移植患者之间的比较。

主要发现

  • LNG-IUS组与对照组持续妊娠率分别为41.8%和29.5%(P=0.017)。
  • 逻辑回归分析显示,使用LNG-IUS的持续妊娠校正OR=1.628(95%CI 1.011-2.622)。
  • LNG-IUS组与对照组着床率分别为32.1%和22.1%(P=0.005)。
  • LNG-IUS组与对照组临床妊娠率分别为44%和33.5%(P=0.045)。

临床怎么用

  • 作者认为本研究结果对未来随机对照试验评估LNG-IUS预处理效果提供了一定支持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Does the use of a levonorgestrel-releasing intrauterine system (LNG-IUS) improve the ongoing pregnancy rate of vitrified-warmed embryo transfer in women with adenomyosis undergoing IVF? DESIGN: This retrospective study included 358 women with adenomyosis undergoing IVF. Of these, 134 women were enrolled in the LNG-IUS group and another 224 women were in the control group. All women were screened for adenomyosis by transvaginal ultrasound and magnetic resonance imaging (MRI). There was no significant difference in the ages of women, FSH, cause of infertility, body mass index, total dose of gonadotrophin used and number of oocytes collected between the two groups. All comparisons performed were between patients undergoing vitrified-warmed embryo transfer. RESULTS: Statistical differences were found in the ongoing pregnancy rates (41.8% vs 29.5%, P = 0.017) between the LNG-IUS group and control group. Logistic regression analysis showed that the odds ratio (OR) of ongoing pregnancy was significantly increased with LNG-IUS usage (adjusted OR = 1.628, 95% confidence interval 1.011-2.622). Also, differences were found in implantation rates (32.1% vs 22.1%, P = 0.005) and clinical pregnancy rates (44% versus 33.5%, P = 0.045) between the LNG-IUS group and control group. CONCLUSIONS: The results of this study offer some support for evaluating the effect of pretreatment with LNG-IUS in women with adenomyosis in future randomized controlled trials.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Liang Z, Yin M, Ma M, et al. Effect of pretreatment with a levonorgestrel-releasing intrauterine system on IVF and vitrified-warmed embryo transfer outcomes in women with adenomyosis. Reprod Biomed Online. 2019. PMID: 31109894. doi:10.1016/j.rbmo.2019.03.101

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。